NCT07482657: A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus
- State
- Under way
- Phase
- Phase 2
- People
- 150 planned
- Started
- 9 Jul 2026
- Primary completion
- Dec 2026
- Arms
- zelicapavir
- Results
- None posted
- 19 Mar 2026: Trial registered
- 9 Jul 2026: Trial started